Graf Akcie PRTK (Paratek Pharmaceuticals Inc.). Diskuze k akciím PRTK. Aktuální informace PRTK.

Základní informace o společnosti Paratek Pharmaceuticals Inc. (Akcie PRTK)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 234.58M
Hodnota podniku (EV) 410.21M
Tržby 103.599M
EBITDA -33.07
Zisk -54.49
Růst v tržbách Q/Q 516.47 %
Růst v tržbách Y/Y 243.65 %
P/E (Cena vůči ziskům) N/A
Forward P/E -1.83
EV/Sales 3.96
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.01
Price/Sales 2.31
P/FCF N/A
Price/Book -2.34
Účetní hodnota na akcii -2.14
Hotovost na akcii 2.64
FCF vůči ceně -45.21 %
Počet zaměstnanců 197
Tržba na zaměstnance 525.883k
Profit margin -205.74 %
Operating margin -32.44 %
Gross margin 81.56 %
EBIT margin -34.17 %
EBITDA margin -31.92 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -137.74 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets -30.51 %
Return on equity 54.43 %
ROIC -35.66 %
ROCE -22.32 %
Dluhy/Equity -2.73
Čistý dluh/EBITDA -16.76
Current ratio 7.32
Quick Ratio 5.99
Volatilita 4.92
Beta 0.90
RSI 48.67
Cílová cena analytiků 17
Známka akcie (dle analytiků) 1.00
Insider ownership 8.57 %
Institutional ownership 55.58 %
Počet akcií 48.795M
Procento shortovaných akcií 9.69 %
Short ratio 7.32 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk N/A %
Obchodovaná od 2006
Země United States

Finanční výsledky akcie PRTK

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$16.544$17.117$12.616$0.029-$4.342
Cost Of Goods Sold$3.484-----
Gross Profit$13.06$17.117$12.616$0.029-$4.342
Research And Development Expenses$39.554$57.508$60.072$83.46$50.765$5.014
SG&A Expenses$89.135$63.658$36.965$26.4$19.988$5.848
Other Operating Income Or Expenses-$-0.036$-0.159$0.345$0.7-
Operating Expenses$132.173$121.202$97.196$109.515$70.053$12.14
Operating Income$-115.629$-104.085$-84.58$-109.486$-70.053$-7.798
Total Non-Operating Income/Expense$-12.86$-7.769$-3.736$-2.15$-0.807$-10.037
Pre-Tax Income$-128.489$-111.854$-88.316$-111.636$-70.86$-17.835
Income Taxes$0.301$0.502$0.753---
Income After Taxes$-128.79$-112.356$-89.069$-111.636$-70.86$-17.835
Other Income------
Income From Continuous Operations$-128.79$-112.356$-89.069$-111.636$-70.86$-17.835
Income From Discontinued Operations------
Net Income$-128.79$-112.356$-89.069$-111.636$-70.86$-19.762
EBITDA$-116.921$-105.151$-83.312$-107.183$-69.339$-7.602
EBIT$-115.629$-104.085$-84.58$-109.486$-70.053$-7.798
Basic Shares Outstanding33322720173
Shares Outstanding33322720173
Basic EPS$-3.93$-3.57$-3.32$-5.51$-4.29$-7.82
EPS - Earnings Per Share$-3.93$-3.57$-3.32$-5.51$-4.29$-7.82
# 2020 2019 2018 2017 2016 2015
Current Ratio10.05614.41329.5596.47176.946527.0861
Long-term Debt / Capital1.17930.8280.41780.35250.162-
Debt/Equity Ratio-6.57624.81230.71760.54440.1933-
Gross Margin78.941100100100-100
Operating Margin-698.918-608.0797-670.4185-377537.9--179.5947
EBIT Margin-698.918-608.0797-670.4185-377537.9--179.5947
EBITDA Margin-706.7275-614.3074-660.3678-369596.6--175.0806
Pre-Tax Profit Margin-776.6501-653.4673-700.0317-384951.7--410.7554
Net Profit Margin-778.4695-656.4001-706.0003-384951.7--455.1359
Asset Turnover0.06590.0570.07710.0002-0.0395
Inventory Turnover Ratio0.3009-----
Receiveable Turnover1.726468.7432.14230.0898-0.9793
Days Sales In Receivables211.42385.3096170.37774065.345-372.7338
ROE - Return On Equity324.8416-236.1512-107.9912-155.9336-69.9921-18.7295
Return On Tangible Equity318.1884-240.3389-109.2777-160.0562-71.531-19.9094
ROA - Return On Assets-51.2946-37.4281-54.4106-82.2474-48.5615-16.2185
ROI - Return On Investment-58.2547-40.6296-62.8734-100.9678-58.6565-18.7295
Book Value Per Share-0.99551.47492.95193.06495.74936.6045
Operating Cash Flow Per Share-1.51170.35291.7172-1.33244.014595.2363
Free Cash Flow Per Share-1.5170.39261.7096-1.31473.962795.2363